Chemical activators of Neprilysin-2 can induce its activity through various intracellular signaling pathways, primarily those associated with phosphorylation and calcium-dependent mechanisms. N6-Cyclopentyladenosine, through its agonistic action on adenosine A1 receptors, increases intracellular calcium concentration, which can activate calmodulin-dependent protein kinases (CaMK). This activation cascade has the potential to facilitate the phosphorylation of Neprilysin-2, enhancing its proteolytic function. Similarly, Isoproterenol, a beta-adrenoceptor agonist, and Forskolin, an adenylate cyclase activator, both elevate cAMP levels, leading to the activation of protein kinase A (PKA). PKA, in turn, can phosphorylate Neprilysin-2, leading to an increase in its enzymatic activity. Glutamate, through its action on NMDA receptors, can also cause a calcium influx, activating CaMK, which may further engage in the phosphorylation of Neprilysin-2. Histamine, binding to its G-protein-coupled receptors, can raise intracellular calcium levels, potentially triggering pathways that culminate in the activation of Neprilysin-2.
Further, chemicals like Sodium orthovanadate, which inhibits phosphatases, can maintain or increase the phosphorylated state within cells, possibly contributing to the phosphorylation and activation of Neprilysin-2. A23187 (Calcimycin), as a calcium ionophore, directly increases intracellular calcium levels, which can activate kinases that phosphorylate and activate Neprilysin-2. Rolipram and IBMX, both phosphodiesterase inhibitors, prevent the breakdown of cAMP, thus sustaining PKA activity that can lead to Neprilysin-2 activation. Bay K 8644, by acting as a calcium channel agonist, can also lead to increased calcium levels intracellularly, potentially affecting Neprilysin-2 activity through similar calcium-dependent activation mechanisms. These chemical interactions underscore the complexity of intracellular signaling pathways and demonstrate how alterations in these pathways can modulate the activity of proteins like Neprilysin-2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N6-Cyclopentyladenosine | 41552-82-3 | sc-204117 | 50 mg | $120.00 | 2 | |
As an adenosine A1 receptor agonist, it can increase the intracellular calcium level, which in turn could activate calmodulin-dependent protein kinases (CaMK), potentially leading to the phosphorylation and thus activation of NEP2. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenoceptor agonist that can increase cAMP levels, potentially leading to the activation of PKA. PKA could then phosphorylate NEP2, thereby increasing its protease activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylate cyclase, increasing cAMP levels and subsequently activating PKA, which could phosphorylate and activate NEP2. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
As a neurotransmitter, it can activate NMDA receptors, potentially causing an influx of calcium ions which could then activate CaMK, leading to the phosphorylation and activation of NEP2 in neurons. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to its G-protein-coupled receptors and can increase intracellular calcium levels, which might indirectly lead to activation of NEP2 via CaMK-dependent pathways. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
A phosphatase inhibitor that can increase phosphorylation levels within the cell, potentially increasing the phosphorylation and activation of NEP2. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium concentration, possibly leading to the activation of NEP2 through calcium-dependent phosphorylation pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, potentially leading to increased PKA activity and subsequent phosphorylation and activation of NEP2. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, raises intracellular cAMP levels, which could lead to the activation of PKA and subsequent phosphorylation and activation of NEP2. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
A calcium channel agonist that could increase intracellular calcium levels, potentially leading to the activation of NEP2 through activation of calcium-dependent proteins and kinases. | ||||||